Modulation by the ATP/GTP ratio of the phosphorylation level of P-glycoprotein and of various plasma membrane proteins of KB-V1 multidrug resistant cells

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2363-2375

  Lelong Rebel, Isabelle H ^a   Rebel, Gérard ^a   Cardarelli, Carol O ^b   Pastan, Ira ^b   Gottesman, Michael M ^b  

^a IRCAD   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ATP; GTP; KB V1; Kinases; Plasma membrane; Protein phosphorylation; Vesicles

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CASEIN KINASE II; CELL MEMBRANE PROTEIN; CYCLIC AMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GLYCOPROTEIN P; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; MASTOPARAN; PHOSPHORUS 32; PROTEIN KINASE C INHIBITOR;

ARTICLE; CELL STRAIN; CELL STRAIN KB V1; CONTROLLED STUDY; ENZYME ACTIVITY; GEL; HUMAN; HUMAN CELL; HYDROLYSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; CELL MEMBRANE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GUANOSINE TRIPHOSPHATE; HUMANS; KB CELLS; MEMBRANE PROTEINS; P-GLYCOPROTEIN; PEPTIDES; PHOSPHORUS RADIOISOTOPES; PHOSPHORYLATION; PROTEIN KINASE C; WASP VENOMS;

EID: 0041305039     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Hunter T and Cooper JA: Protein-tyrosine kinases. Annu Rev Biochem 54: 897-930, 1985.
2. Edelman AM, Blumenthal DK and Krebs EG: Protein serine/threonine kinases. Annu Rev Biochem 56: 567-613, 1987.
3. Center M: Mechanisms regulating cell resistance to adriamycin. Biochem Pharmacol 34: 1471-1476, 1985.
4. Mellado W and Horwitz SB: Phosphorylation of the multidrug resistance associated glycoproteins. Biochemistry 26: 6900-6904, 1987.
5. Hamada H, Hagiwara KI, Nakajima T and Tsuruo T: Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effect of verapamil, trifluoperazine, and phorbol esters. Cancer Res 47: 2860-2865, 1987.
6. Meyers MB: Protein phosphorylation in multidrug Chinese hamster cells. Cancer Commun 1: 233-241, 1989.
7. Chambers TC, Mc Avoy EM, Jacobs JW and Eilon G: Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human carcinoma cells. J Biol Chem 265: 7679-7686, 1990.
8. Ma L, Marquardt D, Takemodo L and Center MS: Analysis of P glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593-5599, 1991.
9. Bates SE, Currier SJ, Alvarez M and Fojo AT: Modulation of P glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry 31: 6366-6372, 1992.
10. Lelong IH, Cardarelli C, Gottesman MM and Pastan I: ATP/GTP modulation of protein phosphorylation in transporting plasma membrane vesicles from KB-V1 multidrug resistant cells. Biochemistry 33: 8921-8929, 1994.
11. Tanaka S, Currier SJ, Bruggemann EP, Ueda K, Germann UA, Pastan I and Gottesman MM: Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter. Biochem Biophys Res Commun 166: 180-186, 1990.
12. Akiyama, S-i, Fojo A, Pastan I and Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Gene 11: 117-126, 1985.
13. Shen D-W, Cardarelli C, Hwang J, Cornwell MM, Richert N, Ishii S, Pastan I and Gottesman MM: Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261: 7762-7770, 1986
14. Cornwell MM, Gottesman MM and Pastan I: Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem 261: 7921-7928, 1986.
15. Lever JE: Active amino acid transport in plasma membrane vesicles from simian virus 40-transformed mouse fibroblasts. Characteristics of electrochemical Na+ gradient-stimulated uptake. J Biol Chem 252: 1990-1997, 1977.
16. Lelong, IH, Padmanabhan R, Lovelace E, Pastan I and Gottesman MM: ATP and GTP as alternative energy sources for vinblastine transport by P- 170 in KB-V1 plasma membrane vesicles. FEBS Letters 304: 256-260, 1992.
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1992.
18. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
19. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
20. Shugar D: The NDP phosphate donor in kinase reactions: is ATP a monopolist? Acta Biochem Polon 43: 9-24, 1996.
21. Pype S and Slegers H: Inhibition of casein kinase II by dinucleoside polyphosphates. Enzymes Protein 47: 14-21, 1993.
22. Hataway GM and Traugh JA: Casein kinases. Multipotential protein kinases. Curr Top Cell Regul 21: 101-127, 1982.
23. Ross EM and Higashima T: Regulation of G protein activation by mastoparan and other cationic peptides. Methods in Enzymol 237: 26-37, 1994.
24. Van Dijk AMA, King GB, Schotman P and Gispen WH: GTP-sensitive phosphorylation of proteins in a postmitochondrial supernatant from rat brainstem affected by ACTH1-24. Neurochem Res 6: 847-859, 1981.
25. Kondratev VE, Shchipakina TG and Budantsev A Y: Detection of specific substrates of endogenous phosphorylation with GTP in synaptic protein membranes. Ukr Biokhim Zh 58: 3-8, 1986.
26. Garman D, Albers L and Center M: Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin. Biochem Pharmacol 32: 3633-3637, 1983.
27. Marsh W and Center M: In vitro phosphorylation and the identification of multiple protein changes in membrane of Chinese hamster lung resistant to adriamycin. Biochem Pharmacol 34: 4180-4184, 1985.
28. Sarkadi B, Enyedi A, Földes-Papp, Z and Gardos G: Molecular characterization of the in situ red cell membrane calcium pump by limited proteolysis. J Biol Chem 261: 9552-9557, 1986.
29. Cameselle JC, Costas MJ, Günter-Sillero MA and Sillero A: Two low Km hydrolytic activities on dinucleoside 5′, 5′″-P1, P4 tetraphosphate in rat liver. J Biol Chem 259: 2879-2885, 1984.
30. Olgivie A, Lüthje J, Pohl U and Busse R: Identification and partial characterization of an adenosine (5′) tetraphospho (5′) adenosine hydrolase on intact bovine aortic endothelial cells. Biochem J 259: 97-103, 1989.
31. Guranowski A and Sillero A: Enzyme cleaving diadenosine polyphosphates. In: AP4A and Other Dinucleoside Polyphosphate. Mc Lennan AG Ed. CRC Press Boca Raton FL (USA) pp 81-133, 1992.
32. Oda A, Druker BJ, Ariyoshi H, Smith M and Salzman EW: TMB-8 and dibukaine induce tyrosine phosphorylation and dephosphorylation of a common set of proteins in platelets. Am J Physiol 269: C118-C125, 1995.
33. Rubin R P, Shen J C and Laychock SG: Evidence for the mobilization of cellular calcium by prostacyclin in cat adrenocortical cells: the effect of TMB-8. Cell Calcium 1: 391-400, 1980.
34. 2+ antagonist 8-(N,N-diethylamino)octyl-3,4,5 trimetoxybenzoate on rabbit platelets conversion of arachidonic acid to thromboxane. Prostaglandins 21: 571-579, 1981.
35. Smolen JE, Korchak HM and Weissman G: The roles of extracellular and intracellular calcium in lysosomal enzyme release and superoxide anion generation by human neutrophils. Biochim Biophys Acta 677: 512-520, 1981.
36. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M and Tomita F: Staurosporine, a potent inhibitor of phospholipid/Ca dependent protein kinase. Biochem Biophys Res Commun 135: 397-402, 1986.
37. Kiyoto I, Yamamoto S, Aizu E and Kato R: Staurosporine, a potent protein kinase C inhibitor, fails to inhibit 12-O-tetradecanoylphorbol-13-acetate caused ornithine decarboxylase induction in isolated mouse epidermal cells. Biochem Biophys Res Commun 148: 740-746, 1987.
38. Rüegg UT and Burgess GM: Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 10: 218-220, 1989.
39. Dlugosz AA and Yuspa SH: Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro. Cancer Res 51: 4677-4684, 1991.
40. Kamiya Biomedical Company: Technical Notes on Protein Kinase Inhibitors.
41. Treharne KJ, Marshall LJ and Mehta A: A novel chloride dependent GTP utilizing protein kinase in plasma membranes from human respiratory epithelium. Am J Physiol 267: L592-L601, 1994.
42. Sato W, Yusa K, Naito M and Tsuruo T: Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 17: 1252-1257, 1990.
43. Anschutz AL, Um HD, Siegel NR, Veron M and Klein C: P36, a Dictyostelium discoideum protein whose phosphorylation is stimulated by GDP, is homologous to the a-subunit of succinyl-CoA synthetase. Biochim Biophys Acta 1162: 40-46, 1993.
44. Chlebowski JF and Coleman JE: Presteady state kinetics of phosphorothioate hydrolysis by alkaline phosphatase. Rate-limiting dephosphorylation at alkaline pH. J Biol Chem 247: 6007-6010, 1972.
45. Mushak P and Coleman J: Hydrolysis of a stable oxygen ester of phosphorothioic acid by alkaline phosphatase. Biochemistry 11: 201-205, 1972.
46. Eckstein F: Phosphorothioate analogues of nucleotides-Tools for the investigation of biological processes. Angew Chem Int Ed Engl 22: 423-439, 1983.
47. Eckstein F: Nucleoside phosphorothioates. Annu Rev Biochem 54: 367-402, 1985.
48. Yount RP, Babcock D, Ballantyne WM and Ojala D: Adenylyl imidodiphosphate, an adenosine triphosphate analog containing a P-N-P linkage. Biochemistry 10: 2484-2489, 1971.
49. Fernley HN: Thiophosphorylation of alkaline phosphatase. Nature New Biology 241: 110-111, 1973.
50. Hauptmann M, Wilson DF and Erecinska M: Effects of ATPγS in isolated rat brain synaptosomes. Biochem Pharmacol 34: 1247-1254, 1985.
51. Gratecos D and Fischer E H: Adenosine 5′-O (3-thiotriphosphate) in the control of phosphorylase activity. Biochem Biophys Res Commun 58: 960-967, 1974.
52. Gergely, P, Vereb G and Bot G: Thiophosphate-activated phosphorylase kinase as a probe in the regulation of phosphorylase phosphatase. Biochim Biophys Acta 429: 809-816, 1976.
53. Morgan M, Perry SV and Ottaway J: Myosin light-chain phosphatase. Biochem J 157: 687-697, 1976.
54. Sherry J M, Gorecka A, Aksoy MO, Dabrowska R and Hartshorne J: Roles of calcium and phosphorylation in the regulation of the activity of gizzard myosin. Biochemistry 17: 4411-4418, 1978.
55. 35S]ATPγS. J Biol Chem 254: 11148-11153, 1979.
56. Sun IYC, Johnson EM and Allfrey VG: Affinity purification of newly phosphorylated protein molecules. Thiophosphorylation and recovery of histones H1, H2B and H3 and the high mobility group protein HMG-1 using adenosine 5′-O-(3-thiotriphosphate) and cyclic AMP-dependent protein kinase. J Biol Chem 255: 742-747, 1980.
57. Franks K, Cooke R and Stull J T: Myosin phosphorylation decreases the ATPase activity of cardiac myofibrils. J Mol Cell Cardiol 16: 597-604, 1984.
58. Bialojan C, Morano I and Rüegg JC: Different phosphorylation pattern of cardiac myosin light chains using ATP and ATPγS as substrates. Mol Cell Cardiol 20: 575-578, 1988.
59. Kubota, Y, Nomur M, Kamm KE, Mumby MC and Stull JT: GTPγS-dependent regulation of smooth muscle contractile elements. Am J Physiol 262: C 405-C 410, 1992.
60. Noda M, Yasuda Fukazawa C, Moriishi K, Kato T, Okuda T, Kurokawa K and Takuwa Y: Involvement of rho in GTPγS-induced enhancement of phosphorylation of a 20kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Letters 367: 246-250, 1995.
61. Birnbaumer L, Swartz TL, Abramowitz J, Mintz PW and Iyengar R: Transient and steady state kinetics of the interaction of guanyl nucleotides with the adenylyl cyclase system from rat liver plasma membranes. J Biol Chem 255: 3542-3551,1980.
62. Breitwieser GE and Szabo G: Mechanism of muscarinic receptor-induced K+ channel activation as revealed by hydrolysis resistant GTP analogues. J Gen Physiol 91: 469-493, 1988.
63. 32P]GTP. FEBS Lett 122: 166-170, 1980.
64. 32GTP. Evidence for a formation of a high energy phosphoprotein. Mol Cell Endocrinol 63: 175-188, 1989.
65. Hosey MM and Tao M: Selective phosphorylation of erythrocyte membrane proteins by the solubilized membrane protein kinases. Biochemistry 16: 4578-4583, 1977.
66. Babinska A and Ehrlich YH: Phosphorylation of neuronal specific proteins by a GTP preferring protein kinase. J Neurochem 52: S107, 1989.
67. Takahashi K, Isobe M and Muto S: Mastoparan induces an increase in cytosolic calcium ion concentration and subsequent activation of protein kinases in tobacco suspension culture cells. Biochim Biophys Acta 1401: 339-346, 1998.
68. Barancik M, Stefankova Z and Breier A: Effect of phorbol myristate acetate (PMA) on P-glycoprotein-mediated vincristine resistance on L1210 cells. Gen Physiol Biophys 14: 171-174, 1995.
69. Krebs E G: Protein phosphorylation and cellular regulation I. Angew Chem Int Ed Engl 32: 1122-1129, 1993.
70. Cheatham B and Kahn CR: Insulin action and the insulin signaling network. Endocrine Reviews 16: 117-142, 1995.
71. Chang LF and Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-41, 2001.
72. Otero A De S: Transphosphorylation and G protein activation. Biochem Pharmacol 39: 1399-1404, 1990.
73. Traut T W: Physiological concentrations of purine and pyrimidines. Mol Cell Biochem 140: 1-22, 1994.
74. Sonneman J and Mutzel R: Cytosolic nucleoside diphosphate kinase associated with the translation apparatus may provide GTP for protein synthesis. Biochem Biophys Res Commun 209: 490-496, 1995.
75. Uhlinger DJ, Burnham DN and Lambeth JD: Nucleoside triphosphate requirements for superoxide generation and phosphorylation in a cell free system from human neutrophils. J Biol Chem 266: 20990-20997, 1991.
76. Kowluru A and Metz SA: Characterization of nucleoside diphosphokinase activity in human and rodent pancreatic β cells. Evidence for its role in the formation of guanosine triphosphate, a permissive factor for nutrient-induced insulin secretion. Biochemistry 33: 12495-12503, 1994.
77. Krishnan KS, Rikhy R, Rao S, Shivalkar M, Mosko M, Narayanan R, Etter P, Estes PS and Ramaswami M: Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron 30: 197-210, 2001.
78. Chen PL, Scully P, Shew JY, Wang JY and Lee WH: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198, 1989.
79. Qian Y, Luckey C, Horton L, Esser M and Templeton D: Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12: 5363-5372, 1992.
80. Juan CC and Wu FYH: Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34cdc2 kinase and phosphatase. Biochem Biophys Res Commun 190: 907-913, 1993.
81. Gu X, Preuss U, Gu T and Yu R: Regulation of sialyltransferase activities by phosphorylation and dephosphorylation. J Neurochem 64: 2295-2302, 1995.
82. Mahan L C and Insel PA: Expression of β-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response. Mol Pharmacol 29: 16-22, 1986.